BioMarin (BMRN) Posts Strong Q2 Growth, Advances Rare Disease Research
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best growth stocks to buy according to analysts. On August 4, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) released its Q2 2025 earnings.